Origin Bancorp, Inc. Reports Earnings For First Quarter 2025

(NYSE:OBK), RUSTON, La., April 23, 2025 (GLOBE NEWSWIRE) — Origin Bancorp, Inc. (NYSE: OBK) (“Origin,” “we,” “our” or the “Company”), the holding company for Origin Bank (the “Bank”), today announced net income of $22.4 million, or $0.71 diluted earnings per share (“EPS”) for the quarter ended March 31, 2025, compared to net income of $14.3 […]

Gouverneur Bancorp, Inc. Announces Fiscal 2025 Second Quarter and Six Months Results

(PinkSheets:GOVB),(Pinksheets:GOVB), GOUVERNEUR, N.Y., April 23, 2025 (GLOBE NEWSWIRE) — Gouverneur Bancorp, Inc. (OTCQB: GOVB) (the “Company”), the holding company for Gouverneur Savings and Loan Association (the “Bank”), today announced the Company's results for the second quarter and six months of fiscal year 2025, ended March 31, 2025. The Company reported net income of $118,000, or

Palvella Therapeutics Announces Abstract Highlighting the Estimated Diagnosed Prevalence and Annual Incidence of Lymphatic Malformations in the U.S. Accepted for Poster Presentation at the 82nd Annual Meeting of the Society for Investigative Dermatology

(NASDAQ:PVLA), Quantitative analysis of medical claims indicates an estimated 44,553 to 92,967 diagnosed U.S. patients with lymphatic malformations (LMs) with cutaneous involvement Estimates of annual incidence of LMs with cutaneous involvement to be highlighted in the poster presentation Poster to be presented on Thursday, May 8, 2025, 4:30-6:00 pm PT WAYNE, Pa., April 23, 2025

Plexus Announces Fiscal Second Quarter Financial Results

(NASDAQ:PLXS), NEENAH, WI, April 23, 2025 (GLOBE NEWSWIRE) — Plexus Corp. (NASDAQ: PLXS) today announced financial results for our fiscal second quarter ended March 29, 2025, and guidance for our fiscal third quarter ending June 28, 2025. Reports fiscal second quarter 2025 revenue of $980 million, GAAP operating margin of 5.0% and GAAP diluted EPS

Univest Financial Corporation Reports First Quarter Results

(NASDAQ:UVSP), SOUDERTON, Pa., April 23, 2025 (GLOBE NEWSWIRE) — Univest Financial Corporation (“Univest” or the “Corporation”) (NASDAQ: UVSP), parent company of Univest Bank and Trust Co. (the “Bank”) and its insurance, investments and equipment financing subsidiaries, announced net income for the quarter ended March 31, 2025 of $22.4 million, or $0.77 diluted earnings per share,

King Salman Park Foundation Selects Parsons for Project Management Office Services

(NYSE:PSN), CHANTILLY, Va., April 23, 2025 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE: PSN) announced today that it has been awarded a contract for Project Management Office (PMO) services by the King Salman Park Foundation for King Salman Park. This 25-month contract marks new work for Parsons. King Salman Park is one of the world's most

Eagle Bancorp, Inc. Announces First Quarter 2025 Results and Cash Dividend

(NASDAQ:EGBN), BETHESDA, Md., April 23, 2025 (GLOBE NEWSWIRE) — Eagle Bancorp, Inc. (“Eagle”, the “Company”) (NASDAQ: EGBN), the Bethesda-based holding company for EagleBank, one of the largest community banks in the Washington D.C. area, reported its unaudited results for the first quarter ended March 31, 2025. Eagle reported net income of $1.7 million or $0.06

TFI International Reports on Shareholders’ Voting Results for the Election of Directors

TFI International Reports on Shareholders' Voting Results for the Election of Directors GlobeNewswire April 23, 2025 MONTREAL, April 23, 2025 (GLOBE NEWSWIRE) — The Board of Directors of TFI International Inc. (NYSE and TSX: TFII), a North American leader in the transportation and logistics industry, held its Annual Meeting of shareholders earlier today. All candidates

Iovance Biotherapeutics Announces Participation in Upcoming Scientific Congresses

Iovance Biotherapeutics Announces Participation in Upcoming Scientific Congresses GlobeNewswire April 23, 2025 SAN CARLOS, Calif., April 23, 2025 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, announced that pre-clinical data for IOV-5001, a genetically engineered,

Jayud Global Logistics Files 2024 Annual Report on Form 20-F

Jayud Global Logistics Files 2024 Annual Report on Form 20-F GlobeNewswire April 23, 2025 SHENZHEN, China, April 23, 2025 (GLOBE NEWSWIRE) — Jayud Global Logistics Limited (NASDAQ: JYD) (“Jayud” or the “Company”), a leading end-to-end supply chain solution provider based in Shenzhen specializing in cross-border logistics, today announced that it filed its annual report on

Scroll to Top